
BlackRock
BMEBlackRock Health Sciences Trust Price (BME)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
13,943,973
(0)%
Cash Flow Statement
BlackRock Health Sciences TrustCurrency: USD
YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||||||
Net Income | 113.23M
+0% |
79.56M
-30% |
59.12M
-26% |
-26,471,079.00
-145% |
20.02M
-176% |
23.45M
+17% |
|||||||||||||
Depreciation And Amortiz... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Stock-Based Compensat... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Change In Working Capital | |||||||||||||||||||
Accounts Receivables | 0.00 | 0.00 | 5.45k | -146,886.00 | -17,819.00 | 215.91k | |||||||||||||
Accounts Payables | 0.00 | -267,876.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Other Working Capital | 0.00 | -117,210.00 | 240.75k | 471.97k | -747,582.00 | 293.36k | |||||||||||||
Other Non-Cash Items | -1,698,337,096.00 | -98,526,200.00 | -80,921,205.00 | 25.27M | 12.77M | 41.56M | |||||||||||||
Net Cash Provided By Op... | -1,515,004,941.00
+0% |
-19,350,858.00
-99% |
-21,555,677.00
+11% |
-874,045.00
-96% |
32.02M
-3,763% |
65.52M
+105% |
|||||||||||||
Investing Activities | |||||||||||||||||||
Investments In Propert... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Sales Maturities Of Inve... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Other Investing Activities | 0.00 | -970,245.00 | -35,549.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Net Cash Used For Inv... | 0.00
+0% |
-970,245.00
+0% |
-35,549.00
-96% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
|||||||||||||
Financing Activities | |||||||||||||||||||
Debt Repayment | 0.00 | 0.00 | 0.00 | 2.92k | 57.77k | -60,686.00 | |||||||||||||
Common Stock Issued | 0.00 | 45.09M | 50.33M | 33.62M | 3.02M | 0.00 | |||||||||||||
Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -29,532,715.00 | |||||||||||||
Dividends Paid | 0.00 | -25,648,370.00 | -29,003,964.00 | -32,725,758.00 | -35,099,184.00 | -35,922,238.00 | |||||||||||||
Other Financing Activities | 1.52B | 0.00 | 20.43k | -19,930.00 | -497.00 | 0.00 | |||||||||||||
Net Cash Used/Provide... | 1.52B
+0% |
19.44M
-99% |
21.34M
+10% |
876.17k
-96% |
-32,021,232.00
-3,755% |
-65,515,639.00
+105% |
|||||||||||||
Effect Of Forex Changes... | 19.00 | 0.00 | -1.00 | 32.00 | -28.00 | -7.00 | |||||||||||||
Net Change In Cash | 9.15M | 10.18M | -210,736.00 | 2.16k | -2,584.00 | 5.51k | |||||||||||||
Cash At Beginning Of Per... | 100.00k | 125.21k | 211.70k | 960.00 | 3.12k | 534.00 | |||||||||||||
Cash At End Of Period | 9.25M | 211.70k | 960.00 | 3.12k | 534.00 | 6.05k | |||||||||||||
Additional Metrics: | |||||||||||||||||||
Operating Cash Flow | -1,515,004,941.00 | -19,350,858.00 | -21,555,677.00 | -874,045.00 | 32.02M | 65.52M | |||||||||||||
Capital Expenditure | 0.00 | 0.00 | -4.00 | -1.00 | 0.00 | 0.00 | |||||||||||||
Free Cash Flow | -1,515,004,941.00
+0% |
-19,350,858.00
-99% |
-21,555,677.00
+11% |
-874,045.00
-96% |
32.02M
-3,763% |
65.52M
+105% |